Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

UpHealth, Inc. UPH NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
27/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

UpHealth, Inc. (UPH) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.30. It has a SharesGrow Score of 26/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $159M, +1111.2%/yr average growth. Net income is $223M (loss), growing at -8009.1%/yr. Net profit margin is -140.4% (negative). Gross margin is 44.2% (-33.9 pp trend).

Balance sheet: total debt is $157M against $105M equity (Debt-to-Equity (D/E) ratio 1.5, leveraged). Current ratio is 0.63 (tight liquidity). Debt-to-assets is 46.3%. Total assets: $340M.

Analyst outlook: 2 / 3 analysts rate UPH as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 36/100 (Fail), Future 55/100 (Partial), Income 10/100 (Fail).

UPH SharesGrow Score Overview

40/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 36/100
Gross margin is + market cap
FUTURE 55/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — UPH

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
UPH: +1111.2%/yr revenue is, -8009.1%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
36/100
UPH: Gross margin is 44.2% (-33.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 36/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
55/100
Analyst outlook: 2 / 3 analysts rate UPH as buy (67%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
UPH: Net profit margin is -140.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.25-3.19
Volume348.73K
Avg Volume (30D)245.88K
Market Cap$5.33M
Beta (1Y)0.51
Share Statistics
EPS (TTM)-15.17
Shares Outstanding$14.7M
IPO Date2019-07-01
Employees611
CEOMartin S. A. Beck
Financial Highlights & Ratios
Revenue (TTM)$158.8M
Gross Profit$70.16M
EBITDA$-2.59M
Net Income$-222.94M
Operating Income$-25.04M
Total Cash$15.56M
Total Debt$157.48M
Net Debt$141.93M
Total Assets$339.8M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.03
Analyst Forecast
Rating ConsensusBuy
Analysts Covering3
Buy 67% Hold 33% Sell 0%
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS91532B2007

Price Chart

Track all markets on TradingView
UPH
UpHealth, Inc. ↗  ·  NYSE
Healthcare • Medical - Healthcare Information Services
0.25 52WK RANGE 3.19

People Also View

SHCR
SHCR
Sharecare, Inc.
$1.43
-0.35%
 LTRY
LTRY
Lottery.com Inc.
$1.37
+6.20%
 FEMY
FEMY
Femasys Inc.
$0.43
-0.28%
 ENSC
ENSC
Ensysce Biosciences, Inc.
$0.54
+2.90%
 ATIP
ATIP
ATI Physical Therapy, Inc.
$0.68
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message